Posts for Vanda Pharmaceuticals Inc. ($VNDA)

Explore Vanda Pharmaceuticals Inc.'s 8-K filing detailing stock structure, SEC compliance, and financial reporting. Key insights on Common Stock and Preferred Stock rights.

Explore Vanda Pharmaceuticals Inc.'s 2024 financial report, highlighting revenue growth, R&D investments, and ongoing legal challenges. Key insights for investors considering a hold position.

Explore Vanda Pharmaceuticals' latest 8-K report detailing stock structure, compliance, and key corporate updates as of February 13, 2025. Essential for investors!